PDCD1 and neoplasm: The over activation of PD-1/PD-L1 signaling pathway negatively regulates the function of T cells, which cancels the immune system surveillance function and promotes the escape of tumor cells.197 Therefore, blocking the interaction of PD-1 and PD-L1 maintain the T cells immune function may be a potential strategy for tumor treatment (Fig. 11a).